Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 2/1999

01-04-1999

A pooled analysis of case-control studies of thyroid cancer ¶II. Menstrual and reproductive factors

Authors: Eva Negri, Luigino Dal Maso, Elaine Ron, Carlo La Vecchia, Steven D. Mark, Susan Preston-Martin, Anne McTiernan, Laurence Kolonel, Yasuhiko Yoshimoto, Fan Jin, Gun Wingren, Maria Rosaria Galanti, Lennart Hardell, Eystein Glattre, Eiliv Lund, Fabio Levi, Dimitrios Linos, Claudia Braga, Silvia Franceschi

Published in: Cancer Causes & Control | Issue 2/1999

Login to get access
Metadata
Title
A pooled analysis of case-control studies of thyroid cancer ¶II. Menstrual and reproductive factors
Authors
Eva Negri
Luigino Dal Maso
Elaine Ron
Carlo La Vecchia
Steven D. Mark
Susan Preston-Martin
Anne McTiernan
Laurence Kolonel
Yasuhiko Yoshimoto
Fan Jin
Gun Wingren
Maria Rosaria Galanti
Lennart Hardell
Eystein Glattre
Eiliv Lund
Fabio Levi
Dimitrios Linos
Claudia Braga
Silvia Franceschi
Publication date
01-04-1999
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 2/1999
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1008880429862

Other articles of this Issue 2/1999

Cancer Causes & Control 2/1999 Go to the issue

OriginalPaper

A pooled analysis of case-control studies of thyroid cancer¶ I. Methods

OriginalPaper

The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States

OriginalPaper

The relation of breast size to breast cancer risk in postmenopausal women (United States)

OriginalPaper

The relationship between diet and breast cancer in men (United States)

OriginalPaper

Calculation of population attributable risk for alcohol and breast cancer (United States)

OriginalPaper

Modification of cancer risk in offspring by parental cancer (Sweden)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits